Could Ginkgo Bioworks Holdings Inc (DNA) stock price achieve new all-time highs if its expected earnings and revenue increase?
Stocks of Ginkgo Bioworks Holdings Inc (NYSE:DNA) traded higher last session on Wall Street, down -7.32% to $1.52. According to the data, Ginkgo Bioworks Holdings Inc (NYSE:DNA) has 9 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
There’s Still Time to Buy Ginkgo Bioworks Holdings Inc (NYSE:DNA) Stock
In yesterday’s Wall Street session, Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares traded at $1.33, down -1.48% from the previous session. 9 analysts cover Ginkgo Bioworks Holdings Inc (NYSE:DNA), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $12.00 […]
Does Ginkgo Bioworks Holdings Inc (NYSE:DNA) presents a BIG investment opportunity?
In yesterday’s Wall Street session, Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares traded at $1.49, down -5.10% from the previous session. As of this writing, 9 analysts cover Ginkgo Bioworks Holdings Inc (NYSE:DNA). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $12.00 […]
The shares of Ginkgo Bioworks Holdings Inc (DNA) have recorded the market capitalization of 3.44B
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares traded 1.16% higher at $1.74 on Wall Street last session. In accordance with the data, 9 analysts cover Ginkgo Bioworks Holdings Inc (NYSE:DNA). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $12.00 and a low […]
A Stock With Stellar Fundamentals? Ginkgo Bioworks Holdings Inc (NYSE:DNA): Is It Right For You?
Stocks of Ginkgo Bioworks Holdings Inc (NYSE:DNA) traded higher last session on Wall Street, down -2.26% to $1.73. According to the data, Ginkgo Bioworks Holdings Inc (NYSE:DNA) has 9 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
There is little time left for Ginkgo Bioworks Holdings Inc. (DNA) to reach its 1-year target estimate. How soon will it surpass it?
Ginkgo Bioworks Holdings Inc. (NYSE:DNA) shares traded -4.15% lower at $1.85 on Wall Street last session. In accordance with the data, 9 analysts cover Ginkgo Bioworks Holdings Inc. (NYSE:DNA). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $12.00 and a low […]
Could Ginkgo Bioworks Holdings Inc. (DNA) stock price achieve new all-time highs if its expected earnings and revenue increase?
In yesterday’s Wall Street session, Ginkgo Bioworks Holdings Inc. (NYSE:DNA) shares traded at $2.09, up 0.48% from the previous session. DNA stock price is now 2.72% away from the 50-day moving average and 23.52% away from the 200-day moving average. The market capitalization of the company currently stands at $4.20B. With the price target reduced […]
The shares of Ginkgo Bioworks Holdings Inc. (DNA) have recorded the market capitalization of 4.63B
The stock of Ginkgo Bioworks Holdings Inc. (NYSE:DNA) last traded at $2.25, unchanged from the previous session. Data from the available sources indicates that Ginkgo Bioworks Holdings Inc. (NYSE:DNA) is covered by 9 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high […]
An overview of Ginkgo Bioworks Holdings Inc.’s (DNA) institutional holdings
In yesterday’s Wall Street session, Ginkgo Bioworks Holdings Inc. (NYSE:DNA) shares traded at $1.79, up 6.55% from the previous session. 8 analysts cover Ginkgo Bioworks Holdings Inc. (NYSE:DNA), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $12.00 […]
There is little time left for Ginkgo Bioworks Holdings Inc. (DNA) to reach its 1-year target estimate. How soon will it surpass it?
Ginkgo Bioworks Holdings Inc. (NYSE:DNA) shares traded 2.47% higher at $1.66 on Wall Street last session. In accordance with the data, 8 analysts cover Ginkgo Bioworks Holdings Inc. (NYSE:DNA). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $12.00 and a low […]
